[at noodls] – -Net Sales up 24%, Advanced Wound Care Sales up 67%, Traditional Wound Care Sales up 9%- -DSC127 Drug Program on Track for Phase 3 Start by Year End- Conference call begins at 11:00 a.m. Eastern time today … moreView todays social media effects on DSCIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that the Company will hold a conference call on November 12, 2012 to discuss … moreView todays social media effects on DSCIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration … moreView todays social media effects on DSCIView the latest stocks trending across Twitter. Click to view dashboard […]
